Darryn Bampton has accumulated a wealth of knowledge and expertise over more than 30 years in regulatory affairs and clinical project management within the prescription medicine industry. His experience encompasses steering projects for New Drug Application (NDA) and Marketing Authorization Application (MAA) approvals across a range of therapeutics, including orphan drugs in the field of oncology.
Additionally, he has been involved in the development of small molecules and biologics/ATMP drug products. Darryn's educational background includes a Master of Medical Sciences in Drug Development and a Postgraduate Diploma in Regulatory Affairs.